Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer

in response to

Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer

BearDownAZ

posted on Sep 02, 2019 10:14AM

The TNBC trial is now recruiting in at least four locations in the US:

https://clinicaltrials.gov/ct2/show/NCT03901469

And based on this tweet and this tweet, it sounds like Europe may be in on this too!

https://twitter.com/aftimosp/status/1166650663125864448?s=20

https://twitter.com/aftimosp/status/1166652012538335232?s=20

BearDownAZ

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply